A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours. (2017)


No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/bjc.2017.199

PubMed Identifier: 28664912

Publication URI: http://europepmc.org/abstract/MED/28664912

Type: Journal Article/Review

Volume: 117

Parent Publication: British journal of cancer

Issue: 5

ISSN: 0007-0920